Prevalence of and risk factors for nonalcoholic fatty liver disease: The Dionysos nutrition and liver study
Top Cited Papers
Open Access
- 13 May 2005
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Journal of Hepatology
- Vol. 42 (1), 44-52
- https://doi.org/10.1002/hep.20734
Abstract
The prevalence of and the risk factors for fatty liver have not undergone a formal evaluation in a representative sample of the general population. We therefore performed a cross‐sectional study in the town of Campogalliano (Modena, Italy), within the context of the Dionysos Project. Of 5,780 eligible persons aged 18 to 75 years, 3,345 (58%) agreed to participate in the study. Subjects with suspected liver disease (SLD), defined on the basis of elevated serum alanine aminotransferase (ALT) and γ‐glutamyl‐transferase (GGT) activity, hepatitis B surface antigen (HBsAg), or hepatitis C virus (HCV)‐RNA positivity, were matched with randomly selected subjects of the same age and sex without SLD. A total of 311 subjects with and 287 without SLD underwent a detailed clinical, laboratory, and anthropometrical evaluation. Fatty liver was diagnosed by ultrasonography, and alcohol intake was assessed by using a 7‐day diary. Multinomial logistic regression was used to detect risk factors for normal liver versus nonalcoholic fatty liver disease (NAFLD) and for alcoholic fatty liver (AFLD) versus NAFLD. The prevalence of NAFLD was similar in subjects with and without SLD (25 vs. 20%, P = .203). At multivariable analysis, normal liver was more likely than NAFLD in older subjects and less likely in the presence of obesity, hyperglycemia, hyperinsulinemia, hypertriglyceridemia, and systolic hypertension; AFLD was more likely than NAFLD in older subjects, males, and in the presence of elevated GGT and hypertriglyceridemia, and less likely in the presence of obesity and hyperglycemia. In conclusion, NAFLD is highly prevalent in the general population, is not associated with SLD, but is associated with many features of the metabolic syndrome. (HEPATOLOGY 2005.)This publication has 37 references indexed in Scilit:
- Increased prevalence of fatty liver in arterial hypertensive patients with normal liver enzymes: role of insulin resistanceGut, 2004
- Clinical and histologic spectrum of nonalcoholic fatty liver disease associated with normal ALT valuesJournal of Hepatology, 2003
- Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic ConferenceJournal of Hepatology, 2003
- Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndromeJournal of Hepatology, 2003
- Nonalcoholic steatohepatitis, insulin resistance, and metabolic syndrome: Further evidence for an etiologic associationJournal of Hepatology, 2002
- NASH and insulin resistance: Insulin hypersecretion and specific association with the insulin resistance syndromeJournal of Hepatology, 2002
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Evaluation of Abnormal Liver-Enzyme Results in Asymptomatic PatientsThe New England Journal of Medicine, 2000
- Homeostasis model assessment closely mirrors the glucose clamp technique in the assessment of insulin sensitivity: studies in subjects with various degrees of glucose tolerance and insulin sensitivity.Diabetes Care, 2000
- The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitusJCI Insight, 1999